Cancer Gene Therapy - Publishes original laboratory and clinical research papers, case reports and review articles covering developments in gene transfer and gene therapy as applied to cancer research. Full articles available by subscription.
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
The Journal of Cancer Gene and Cellular Therapies
Cancer Gene Therapy expanded its scope in 2011 to include greater coverage of cellular therapies. Following the recent expansion of research into genetically modified dendritic cells and pluripotent progenitor cells, the journal's new subtitle — "The Journal of Cancer Gene and Cellular Therapies" — reflects its larger mission of supporting the concurrent advancement of gene and cellular therapies.